These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9473726)

  • 1. Suppression of intestinal polyp development by nimesulide, a selective cyclooxygenase-2 inhibitor, in Min mice.
    Nakatsugi S; Fukutake M; Takahashi M; Fukuda K; Isoi T; Taniguchi Y; Sugimura T; Wakabayashi K
    Jpn J Cancer Res; 1997 Dec; 88(12):1117-20. PubMed ID: 9473726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice.
    Kitamura T; Itoh M; Noda T; Matsuura M; Wakabayashi K
    Int J Cancer; 2004 Apr; 109(4):576-80. PubMed ID: 14991580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.
    Jacoby RF; Cole CE; Tutsch K; Newton MA; Kelloff G; Hawk ET; Lubet RA
    Cancer Res; 2000 Apr; 60(7):1864-70. PubMed ID: 10766173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.
    Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF
    Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
    Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2.
    Takahashi M; Fukutake M; Yokota S; Ishida K; Wakabayashi K; Sugimura T
    J Cancer Res Clin Oncol; 1996; 122(4):219-22. PubMed ID: 8601574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, against PhIP-induced mammary carcinogenesis.
    Kawamori T; Nakatsugi S; Ohta T; Sugimura T; Wakabayashi K
    Adv Exp Med Biol; 2002; 507():371-6. PubMed ID: 12664612
    [No Abstract]   [Full Text] [Related]  

  • 8. Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice.
    Fukutake M; Nakatsugi S; Isoi T; Takahashi M; Ohta T; Mamiya S; Taniguchi Y; Sato H; Fukuda K; Sugimura T; Wakabayashi K
    Carcinogenesis; 1998 Nov; 19(11):1939-42. PubMed ID: 9855006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
    Jacoby RF; Seibert K; Cole CE; Kelloff G; Lubet RA
    Cancer Res; 2000 Sep; 60(18):5040-4. PubMed ID: 11016626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of mofezolac, a cyclooxygenase-1 selective inhibitor, on intestinal carcinogenesis.
    Kitamura T; Kawamori T; Uchiya N; Itoh M; Noda T; Matsuura M; Sugimura T; Wakabayashi K
    Carcinogenesis; 2002 Sep; 23(9):1463-6. PubMed ID: 12189188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview.
    Famaey JP
    Inflamm Res; 1997 Nov; 46(11):437-46. PubMed ID: 9427063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of nimesulide.
    Bennett A
    Rheumatology (Oxford); 1999 May; 38 Suppl 1():1-3. PubMed ID: 10369398
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
    Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of intestinal polyposis by inhibition of COX-2 in Apc knockout mice.
    Vane J
    Jpn J Cancer Res; 1997 Nov; 88(11):inside front cover. PubMed ID: 9439674
    [No Abstract]   [Full Text] [Related]  

  • 16. The selective cyclooxygenase-2 inhibitor nimesulide prevents Helicobacter pylori-associated gastric cancer development in a mouse model.
    Nam KT; Hahm KB; Oh SY; Yeo M; Han SU; Ahn B; Kim YB; Kang JS; Jang DD; Yang KH; Kim DY
    Clin Cancer Res; 2004 Dec; 10(23):8105-13. PubMed ID: 15585646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and safety of nimesulide and diclofenac in patients with acute shoulder, and a meta-analysis of controlled studies with nimesulide.
    Wober W
    Rheumatology (Oxford); 1999 May; 38 Suppl 1():33-8. PubMed ID: 10369404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nimesulide (Aulin)--the selective COX-2 inhibitor in the treatment of ENT diseases].
    Arcimowicz M; Samoliński B; Gotlib T; Nyckowska J
    Otolaryngol Pol; 2002; 56(4):501-7. PubMed ID: 12378813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cyclooxygenase-2 in primary superficial bladder cancer tissue may predict risk of its recurrence after complete transurethral resection.
    Okajima E; Uemura H; Ohnishi S; Tanaka M; Ohta M; Tani M; Fujimoto K; Ozono S; Okajima E; Hirao Y
    Aktuelle Urol; 2003 Jul; 34(4):256-8. PubMed ID: 14566678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COX selectivity and animal models for colon cancer.
    Oshima M; Taketo MM
    Curr Pharm Des; 2002; 8(12):1021-34. PubMed ID: 11945149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.